Literature DB >> 2571233

Sebum secretion in idiopathic Parkinson's disease: effect of anticholinergic and dopaminergic drugs.

J C Villares1, E A Carlini.   

Abstract

Sebum secretion was measured on the foreheads of 47 unmedicated patients with idiopathic Parkinson's disease, aged 50-81 years and 80 healthy, matched volunteers. Sebum secretion was significantly higher in men patients aged 50-59 years than in controls; no such difference was observed in women of the same age. There was also no difference between patients and volunteers of either gender older than 60 years of age. The effects of either biperiden, L-Dopa + benserazide (a decarboxylase inhibitor) or bromocriptine treatments on sebum secretion and on 5 parkinsonian signs were evaluated over 127 days. There was a significant reduction of all measures during the treatment with the dopaminergic drugs. The only observable effect with biperiden was reduction of tremor. It is discussed whether the sebum suppressive effect of the dopaminergic drugs may be explained through their central effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571233     DOI: 10.1111/j.1600-0404.1989.tb03843.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Skin function and skin disorders in Parkinson's disease.

Authors:  M Fischer; I Gemende; W C Marsch; P A Fischer
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

2.  Is seborrhea a sign of autonomic impairment in Parkinson's disease?

Authors:  E Martignoni; L Godi; C Pacchetti; E Berardesca; G P Vignoli; G Albani; F Mancini; G Nappi
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 3.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications.

Authors:  Satyajit S Shetage; Matthew J Traynor; Marc B Brown; Robert P Chilcott
Journal:  Lipids Health Dis       Date:  2018-08-21       Impact factor: 3.876

5.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

6.  A laboratory-based study on patients with Parkinson's disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production.

Authors:  Valentina S Arsic Arsenijevic; Danica Milobratovic; Aleksandra M Barac; Berislav Vekic; Jelena Marinkovic; Vladimir S Kostic
Journal:  BMC Dermatol       Date:  2014-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.